businessneutral

HCA Healthcare: Earnings Stay Steady, Analysts Tighten Their Views

Nashville, USAMonday, April 27, 2026

Revenue: $19.11 billion
Year‑over‑year growth: +4.3% (in line with expectations)

Adjusted EPS: $7.15
Year‑over‑year increase: +$0.70 (matches forecasts)

CEO Commentary

“The beginning of the year has been dynamic,” the CEO noted, underscoring HCA’s navigation through a shifting health‑care landscape.

2026 Outlook

  • EPS: $29.10 – $31.50 (slightly above the consensus of $30.14)
  • Sales: $76.5 – $80 billion (consensus: $78.68 billion)

Market Reaction

  • Shares closed +2.2% at ~$442.00, reflecting investor confidence in steady performance.

Analyst Adjustments

  • Multiple analysts revised price targets and tightened recommendations following the release, indicating cautious optimism about future growth.

Actions